These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3057851)

  • 21. Renal-metabolic consequences of antihypertensive therapy with diltiazem versus hydrochlorothiazide.
    Zawada ET; Williams L; McClung DE; TerWee JA; Horning J; McNulty R; Thomas M; Simmons J
    Miner Electrolyte Metab; 1987; 13(2):72-7. PubMed ID: 3320720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension.
    Szlachcic J; Tubau JF; Vollmer C; Massie BM
    Am J Cardiol; 1989 Jan; 63(3):198-201. PubMed ID: 2642633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
    Pool PE; Seagren SC; Salel AF
    Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.
    Grassi G; Seravalle G; Brambilla G; Dell'Oro R; Trevano FQ; Fici F; van Bortel L; Mancia G
    Adv Ther; 2017 Jan; 33(12):2173-2187. PubMed ID: 27771847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
    Weir MR; Fagan T; Chrysant S; Flamenbaum W; Kaihlanen PM; Lueg M; Anzalone D
    J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
    Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
    Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
    Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular changes after chronic therapy with enalapril maleate in moderate to severe hypertensive patients.
    Fernandez PG; Kim BK; Snedden W; Nolan R; Ko P
    Curr Med Res Opin; 1984; 9(3):170-83. PubMed ID: 6094104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diltiazem compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Leary WP; van der Byl K
    S Afr Med J; 1988 Jul; 74(1):13-5. PubMed ID: 3388151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hydrochlorothiazide, diltiazem and enalapril on mononuclear cell sodium and magnesium levels in systemic hypertension.
    Abraham AS; Brooks BA; Grafstein Y; Barchilon E; Nubani N; Eylath U; Shemesh O
    Am J Cardiol; 1991 Nov; 68(13):1357-61. PubMed ID: 1951126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
    Goldberg MR; Offen WW
    Drugs; 1988; 36 Suppl 7():83-92. PubMed ID: 3076140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Materson BJ; Reda DJ; Cushman WC; Massie BM; Freis ED; Kochar MS; Hamburger RJ; Fye C; Lakshman R; Gottdiener J
    N Engl J Med; 1993 Apr; 328(13):914-21. PubMed ID: 8446138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
    Larochelle P; Logan AG
    Can Med Assoc J; 1985 Apr; 132(7):801-5. PubMed ID: 3884122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
    JAMA; 1982 Oct; 248(16):2004-11. PubMed ID: 6750167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
    Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
    J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.
    Fiddes R; Heym H; Hilty W; Lewin AJ; Codispoti J; McNally C; Stokes A; Gilderman L
    Clin Ther; 1994; 16(2):209-21. PubMed ID: 8062317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    Clin Pharmacol Ther; 1990 Sep; 48(3):318-24. PubMed ID: 2401129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.